Marshall Wace’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-85,600
| Closed | -$1.06M | – | 3015 |
|
|
2024
Q4 | $1.06M | Sell |
85,600
-407,557
| -83% | -$5.03M | ﹤0.01% | 1586 |
|
|
2024
Q3 | $5.61M | Buy |
493,157
+297,696
| +152% | +$3.39M | 0.01% | 876 |
|
|
2024
Q2 | $1.4M | Buy |
+195,461
| New | +$1.4M | ﹤0.01% | 1396 |
|
|
2024
Q1 | – | Sell |
-247,966
| Closed | -$1.61M | – | 2564 |
|
|
2023
Q4 | $1.61M | Buy |
247,966
+50,975
| +26% | +$331K | ﹤0.01% | 1084 |
|
|
2023
Q3 | $1.86M | Sell |
196,991
-7,583
| -4% | -$71.6K | ﹤0.01% | 1076 |
|
|
2023
Q2 | $2.86M | Sell |
204,574
-68,772
| -25% | -$961K | 0.01% | 1027 |
|
|
2023
Q1 | $5.13M | Buy |
+273,346
| New | +$5.13M | 0.01% | 838 |
|
|
2022
Q3 | – | Sell |
-28,505
| Closed | -$435K | – | 3218 |
|
|
2022
Q2 | $435K | Buy |
28,505
+8,023
| +39% | +$122K | ﹤0.01% | 2195 |
|
|
2022
Q1 | $416K | Buy |
+20,482
| New | +$416K | ﹤0.01% | 2171 |
|
|
2021
Q2 | – | Sell |
-16,601
| Closed | -$303K | – | 2658 |
|
|
2021
Q1 | $303K | Sell |
16,601
-6,364
| -28% | -$116K | ﹤0.01% | 1813 |
|
|
2020
Q4 | $265K | Buy |
+22,965
| New | +$265K | ﹤0.01% | 1545 |
|
|
2020
Q3 | – | Sell |
-67,708
| Closed | -$444K | – | 1953 |
|
|
2020
Q2 | $444K | Buy |
+67,708
| New | +$444K | ﹤0.01% | 1198 |
|
|
2019
Q3 | – | Sell |
-324,328
| Closed | -$1.82M | – | 1923 |
|
|
2019
Q2 | $1.82M | Buy |
324,328
+49,383
| +18% | +$277K | 0.01% | 770 |
|
|
2019
Q1 | $1.17M | Buy |
274,945
+154,393
| +128% | +$656K | 0.01% | 878 |
|
|
2018
Q4 | $494K | Buy |
+120,552
| New | +$494K | 0.01% | 1092 |
|